News

Rehabilitation of Pediatric Retinoblastoma Patients with Ocular Prostheses & Subsequent Modifications

Now online in the Journal of Prosthodontics, a case report co-authored by ACP members, Lydia R. Legg DDS, MS, Zain Uddin Ahmed BDS, Melani Kapetanakos DDS, FACP, Joseph M. Huryn DDS, and Joseph D. Randazzo DMD.

Retinoblastoma is the most common intraocular malignancy in children. Enucleation is a common treatment modality performed for pediatric retinoblastoma patients, and the resultant defects are reconstructed using an ocular prosthesis. This retrospective study evaluated the replacement frequency of prostheses in the pediatric oncologic population.

A review of patients that had ocular prostheses fabricated following enucleation of their retinoblastoma from 2005 to 2019 was completed, and 78 enucleated observations (ocular prosthesis fabricated) were included for analysis. As a child's face grows and develops, so does the volume of anophthalmic socket. Therefore, the ocular prosthesis requires modification for proper fit. The data was analyzed to look at the replacement schedule in different age groups.

The data showed that approximately every 6 months an ocular prosthesis needs to be modified. This data is helpful to set expectations for patients, parents, and providers regarding treatment time and the frequency of ocular prosthesis modification.

Legg, LR, Ahmed, ZU, Solano, AK, Seier, K, O'Hara, BF, Kapetanakos, M, et al. Rehabilitation of pediatric retinoblastoma patients with ocular prostheses and their subsequent modifications: A 15-year retrospective study. J Prosthodont. 2023; 1– 6. https://doi.org/10.1111/jopr.13681

Previous Next

Back to News